213 related articles for article (PubMed ID: 20032471)
1. Nonsynonymous mutations within APOB in human familial hypobetalipoproteinemia: evidence for feedback inhibition of lipogenesis and postendoplasmic reticulum degradation of apolipoprotein B.
Zhong S; Magnolo AL; Sundaram M; Zhou H; Yao EF; Di Leo E; Loria P; Wang S; Bamji-Mirza M; Wang L; McKnight CJ; Figeys D; Wang Y; Tarugi P; Yao Z
J Biol Chem; 2010 Feb; 285(9):6453-64. PubMed ID: 20032471
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein Metabolism in APOB L343V Familial Hypobetalipoproteinemia.
Hooper AJ; Heeks L; Robertson K; Champain D; Hua J; Song S; Parhofer KG; Barrett PH; van Bockxmeer FM; Burnett JR
J Clin Endocrinol Metab; 2015 Nov; 100(11):E1484-90. PubMed ID: 26323024
[TBL] [Abstract][Full Text] [Related]
3. Homozygous familial hypobetalipoproteinemia: A Turkish case carrying a missense mutation in apolipoprotein B.
Yilmaz BS; Mungan NO; Di Leo E; Magnolo L; Artuso L; Bernardis I; Tumgor G; Kor D; Tarugi P
Clin Chim Acta; 2016 Jan; 452():185-90. PubMed ID: 26612772
[TBL] [Abstract][Full Text] [Related]
4. A novel nontruncating APOB gene mutation, R463W, causes familial hypobetalipoproteinemia.
Burnett JR; Shan J; Miskie BA; Whitfield AJ; Yuan J; Tran K; McKnight CJ; Hegele RA; Yao Z
J Biol Chem; 2003 Apr; 278(15):13442-52. PubMed ID: 12551903
[TBL] [Abstract][Full Text] [Related]
5. Phosphatase and tensin homolog (PTEN) regulates hepatic lipogenesis, microsomal triglyceride transfer protein, and the secretion of apolipoprotein B-containing lipoproteins.
Qiu W; Federico L; Naples M; Avramoglu RK; Meshkani R; Zhang J; Tsai J; Hussain M; Dai K; Iqbal J; Kontos CD; Horie Y; Suzuki A; Adeli K
Hepatology; 2008 Dec; 48(6):1799-809. PubMed ID: 19026012
[TBL] [Abstract][Full Text] [Related]
6. Missense mutations in APOB within the betaalpha1 domain of human APOB-100 result in impaired secretion of ApoB and ApoB-containing lipoproteins in familial hypobetalipoproteinemia.
Burnett JR; Zhong S; Jiang ZG; Hooper AJ; Fisher EA; McLeod RS; Zhao Y; Barrett PH; Hegele RA; van Bockxmeer FM; Zhang H; Vance DE; McKnight CJ; Yao Z
J Biol Chem; 2007 Aug; 282(33):24270-83. PubMed ID: 17588943
[TBL] [Abstract][Full Text] [Related]
7. Familial hypobetalipoproteinemia due to apolipoprotein B R463W mutation causes intestinal fat accumulation and low postprandial lipemia.
Noto D; Cefalù AB; Cannizzaro A; Minà M; Fayer F; Valenti V; Barbagallo CM; Tuttolomondo A; Pinto A; Sciumè C; Licata G; Averna M
Atherosclerosis; 2009 Sep; 206(1):193-8. PubMed ID: 19344897
[TBL] [Abstract][Full Text] [Related]
8. Molecular diagnosis of hypobetalipoproteinemia: an ENID review.
Tarugi P; Averna M; Di Leo E; Cefalù AB; Noto D; Magnolo L; Cattin L; Bertolini S; Calandra S
Atherosclerosis; 2007 Dec; 195(2):e19-27. PubMed ID: 17570373
[TBL] [Abstract][Full Text] [Related]
9. Variable phenotypic expression of homozygous familial hypobetalipoproteinaemia due to novel APOB gene mutations.
Di Leo E; Magnolo L; Bertolotti M; Bourbon M; Carmo Pereira S; Pirisi M; Calandra S; Tarugi P
Clin Genet; 2008 Sep; 74(3):267-73. PubMed ID: 18492086
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein B gene mutations and fatty liver in Japanese hypobetalipoproteinemia.
Katsuda S; Kawashiri MA; Inazu A; Tada H; Tsuchida M; Kaneko Y; Nozue T; Nohara A; Okada T; Kobayashi J; Michishita I; Mabuchi H; Yamagishi M
Clin Chim Acta; 2009 Jan; 399(1-2):64-8. PubMed ID: 18848826
[TBL] [Abstract][Full Text] [Related]
11. Aberrant hepatic expression of PPARgamma2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis.
Zhang YL; Hernandez-Ono A; Siri P; Weisberg S; Conlon D; Graham MJ; Crooke RM; Huang LS; Ginsberg HN
J Biol Chem; 2006 Dec; 281(49):37603-15. PubMed ID: 16971390
[TBL] [Abstract][Full Text] [Related]
12. Functional analysis of two novel splice site mutations of APOB gene in familial hypobetalipoproteinemia.
Di Leo E; Magnolo L; Pinotti E; Martini S; Cortella I; Vitturi N; Rabacchi C; Wunsch A; Pucci F; Bertolini S; Calandra S; Tarugi P
Mol Genet Metab; 2009 Feb; 96(2):66-72. PubMed ID: 19084451
[TBL] [Abstract][Full Text] [Related]
13. Reduced intestinal fat absorptive capacity but enhanced susceptibility to diet-induced fatty liver in mice heterozygous for ApoB38.9 truncation.
Lin X; Yue P; Xie Y; Davidson NO; Sakata N; Ostlund RE; Chen Z; Schonfeld G
Am J Physiol Gastrointest Liver Physiol; 2005 Jul; 289(1):G146-52. PubMed ID: 15790761
[TBL] [Abstract][Full Text] [Related]
14.
Vanhoye X; Janin A; Caillaud A; Rimbert A; Venet F; Gossez M; Dijk W; Marmontel O; Nony S; Chatelain C; Durand C; Lindenbaum P; Rieusset J; Cariou B; Moulin P; Di Filippo M
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457099
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of APOB, SAR1B, ANGPTL3, and MTTP in patients with primary hypocholesterolemia in a clinical laboratory setting: Evidence supporting polygenicity in mutation-negative patients.
Blanco-Vaca F; Martin-Campos JM; Beteta-Vicente Á; Canyelles M; Martínez S; Roig R; Farré N; Julve J; Tondo M
Atherosclerosis; 2019 Apr; 283():52-60. PubMed ID: 30782561
[TBL] [Abstract][Full Text] [Related]
16. The production of 85 kDa N-terminal fragment of apolipoprotein B in mutant HepG2 cells generated by targeted modification of apoB gene occurs by ALLN-inhibitable protease cleavage during translocation.
Srivastava N; Cefalu AB; Noto D; Schonfeld G; Averna M; Srivastava RA
Biochem Biophys Res Commun; 2010 Aug; 398(4):665-70. PubMed ID: 20609357
[TBL] [Abstract][Full Text] [Related]
17. Abnormal apolipoprotein B pre-mRNA splicing in patients with familial hypobetalipoproteinaemia.
Di Leo E; Magnolo L; Lancellotti S; Crocè L; Visintin L; Tiribelli C; Bertolini S; Calandra S; Tarugi P
J Med Genet; 2007 Mar; 44(3):219-24. PubMed ID: 17158591
[TBL] [Abstract][Full Text] [Related]
18. Non-alcoholic steatohepatitis-related cirrhosis in a patient with APOB L343V familial hypobetalipoproteinaemia.
Heeks LV; Hooper AJ; Adams LA; Robbins P; Barrett PH; van Bockxmeer FM; Burnett JR
Clin Chim Acta; 2013 Jun; 421():121-5. PubMed ID: 23694813
[TBL] [Abstract][Full Text] [Related]
19. A Rare Mutation in The
Musialik J; Boguszewska-Chachulska A; Pojda-Wilczek D; Gorzkowska A; Szymańczak R; Kania M; Kujawa-Szewieczek A; Wojcieszyn M; Hartleb M; Więcek A
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32093271
[TBL] [Abstract][Full Text] [Related]
20. PCSK9 dominant negative mutant results in increased LDL catabolic rate and familial hypobetalipoproteinemia.
Cariou B; Ouguerram K; Zaïr Y; Guerois R; Langhi C; Kourimate S; Benoit I; Le May C; Gayet C; Belabbas K; Dufernez F; Chétiveaux M; Tarugi P; Krempf M; Benlian P; Costet P
Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2191-7. PubMed ID: 19762784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
